XML 23 R13.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Concentrations | 9 Months Ended
--- | ---
Sep. 30, 2022
Risks and Uncertainties [Abstract] |
CONCENTRATIONS | NOTE 7 – CONCENTRATIONS Customer Concentration For the nine months ended September 30, 2022 and 2021, no customer accounted for over 10% of total revenues from apparel sales included in discontinued operations. For the nine months ended September 30, 2022 and 2021, one licensee accounted for 100% total revenues from customer license fee. Vendor Concentrations For the nine months ended September 30, 2022 and 2021, one licensor accounted for 100% of the Company’s vendor license agreements (see below) related to the Company’s biopharmaceutical operation.

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -URI https://asc.fasb.org/topic&trid=2134479 + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration